GR
Healthcare & Life Sciences
Gracell
Chinagracellbio.com
Gracell is a Healthcare & Life Sciences startup based in China, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Gracell
Based in China, Gracell is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gracell is a global clinical-stage biopharmaceutical company developing next-generation CAR-T cell therapies for cancer and autoimmune diseases using innovative platforms like FasTCART, TruUCART, and SMART CART to improve efficacy and accessibility.
Explore Gracell's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.